Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantern Pharma Inc.

3.46
+0.347611.18%
Volume:9.96K
Turnover:31.86K
Market Cap:37.29M
PE:-1.79
High:3.46
Open:3.14
Low:3.07
Close:3.11
Loading ...
Mar 18, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 29, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 25, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 21, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 20, 2023

Major Issues Report

8-K - Current report
Mar 20, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 18, 2023

Major Issues Report

8-K - Current report